Get started
Author

S. Thomas

Observed names: S Thomas, S. K. Thomas, SK Thomas, Sidney Thomas, Subi Thomas, Sweety Thomas
ORCID: 0009-0008-8199-0726
Observed ORCID: 0009-0008-8199-0726
OpenAlex ID: A5064745168
A review of the effects of pharmaceutical pollutants on humans and aquatic ecosystem
2024 · Jaya Vinny Eapen, Sweety Thomas, et al. · Exploration of Drug Science · 108
P1130: Acalabrutinib in Treatment-naive or Relapsed/refractory Waldenström Macroglobulinemia: 5-year Follow-up of a Phase 2, Single-arm Study
2022 · R. Owen, H. McCarthy, et al. · HemaSphere · 20
Integrative strategies in breast cancer therapy: Conventional approaches, emerging advances, and future challenges
2025 · Jaya Vinny Eapen, Paul George, et al. · ASPET Discovery · 17
Report of consensus panel 2 from the 11th international workshop on Waldenström's macroglobulinemia on the management of relapsed or refractory WM patients
2023 · S D'Sa, JV Matous, et al. · Seminars in Hematology · 16
Communication and Level of AIDS Knowledge Among Homeless African-American Mothers and Their Children
1993 · Isiaah Crawford, Sidney Thomas, et al. · Journal of Health & Social Policy · 15
An Unusual Case of Pulmonary Mucormycosis
2018 · S. Thomas, B. Pawar, et al. · Transplantation Proceedings · 11
Isolated Neurogenic Bladder Associated With Human T-Lymphotropic Virus Type 1 Infection in a Renal Transplant Patient From Central Australia: A Case Report
2018 · S. Nayar, B. Pawar, et al. · Transplantation Proceedings · 6
Effects of Patient Distance from LVAD Implant Center on Outcomes and Quality of Life
2021 · A. Gallandt, M. Prario, et al. · The Journal of Heart and Lung Transplantation · 2
197 A retrospective analysis on systemic lupus erythematosus in the indigenous and non-indigenous population in central australia focussing on treatment and outcomes of lupus nephritis
2017 · P Subramani, S Brady, et al. · Lupus Science & Medicine · 2
PDF
HAART in India
2004 · Binu V John, S Thomas · The Lancet · 2
PDF
Risk factors associated with 30‐day mortality following COVID ‐19 infection in patients receiving kidney replacement therapy in Australia and New Zealand
2025 · Peter Kolovos, Christopher E. Davies, et al. · Internal Medicine Journal · 1
Phase 2 study of intratumoral vidutolimod in combination with intravenous cemiplimab in patients with selected advanced cancer or metastatic cancer: trial in progress
2024 · S. Bhatia, D. Davar, et al. · EJC Skin Cancer · 1
PDF
The Burden of Readmissions in the First Year with an LVAD: Predictors and Associated Quality of Life Outcomes
2021 · M. Prario, N. Sutaria, et al. · The Journal of Heart and Lung Transplantation · 1
P1376: Lenalidomide–based Maintenance After Autologous Hematopoietic Stem Cell Transplant for Patients With High Risk Multiple Myeloma
2022 · O. Pasvolsky, D. Milton, et al. · HemaSphere
Differences in non-metastatic colorectal cancer in young patients – an analysis of the SEER registry
2019 · A. Sampaio Soares, S. Thomas, et al. · European Journal of Surgical Oncology
Outcome and prognostic factors in solitary plasmacytoma.
2010 · V. K. Reed, J. J. Shah, et al. · Journal of Clinical Oncology
Estimating costs of care for patients with newly diagnosed metastatic colorectal cancer (mCRC)
2006 · L. C. Paramore, S. Thomas, et al. · Journal of Clinical Oncology
Rupture of the Glutaeus Minimus Tendon in Patients With Osteoarthritis of the Hip.
2006 · S. Thomas, C Schmid, et al. · Orthopaedic Proceedings
High prevalence of cardiovascular disease risk factors, but inadequate risk factor interventions, in diabetic patients on dialysis or after renal transplantation.
2002 · Mohsen Agharazii, P. Kon, et al. · Research Portal (King's College London)
[Towards certainty in medications].
1969 · S Thomas · PubMed
Works count: 20
Citation count: 202
H-index: 6
I10-index: 6
Year
Topic
Type